Cantargia

1 follower

‌

Cantargia utvecklar en antikroppsbaserad behandling riktad mot målmolekylen IL1RAP som har potential att användas för ett flertal olika cancersjukdomar.

Industries

Headquarters

Stage

Employees

Links

Org chart

Göran Forsberg

CEO

Göran Forsberg

Collapse

Liselotte Larsson

COO

Dominique Tersago

Chief Medical Officer

David Liberg

VP, Research

Lars Thorsson

VP Clinical Development

Nedjad Losic

VP Biometrics

Marie Wallén Öhman

Senior Clinical Director

Ida Markholm

Senior Data Manager/Bioinformatician

Susanne Magnusson

Director Clinical Development

Patrik Renblad

CFO

Teams

Clinical Development Team

9 members

Leadership Team

5 members

Governance and Board Team

8 members

Biometrics and Research Team

4 members

Finance and Operations Team

2 members

Similar companies

Neogene Therapeutics

2 followers

Nuvalent

1 follower

Thermo Fisher Scientific

140 followers

Genentech

142 followers

Gilead Sciences

119 followers

Regeneron

87 followers

Genmab

31 followers

Lonza

25 followers

BeiGene

18 followers

Natera

12 followers

Guardant Health

12 followers

Discover companies